vs
Side-by-side financial comparison of Eastern Bankshares, Inc. (EBC) and HUTCHMED (China) Ltd (HCM). Click either name above to swap in a different company.
Eastern Bankshares, Inc. is the larger business by last-quarter revenue ($295.9M vs $270.8M, roughly 1.1× HUTCHMED (China) Ltd). Eastern Bankshares, Inc. runs the higher net margin — 22.1% vs 0.7%, a 21.3% gap on every dollar of revenue. On growth, Eastern Bankshares, Inc. posted the faster year-over-year revenue change (710.6% vs -16.5%).
Eastern Bank is a bank based in Boston, Massachusetts. Before de-mutualizing in 2020, it was the oldest and largest mutual bank in the United States and the largest community bank in Massachusetts.
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
EBC vs HCM — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $295.9M | $270.8M |
| Net Profit | $65.3M | $2.0M |
| Gross Margin | — | 37.7% |
| Operating Margin | — | -13.2% |
| Net Margin | 22.1% | 0.7% |
| Revenue YoY | 710.6% | -16.5% |
| Net Profit YoY | -34.4% | -83.6% |
| EPS (diluted) | $0.29 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $295.9M | — | ||
| Q4 25 | $37.5M | $270.8M | ||
| Q3 25 | $241.5M | — | ||
| Q2 25 | $244.9M | $277.7M | ||
| Q1 25 | $31.1M | $324.5M | ||
| Q4 24 | $216.5M | — | ||
| Q3 24 | $203.4M | — | ||
| Q2 24 | $154.0M | $305.7M |
| Q1 26 | $65.3M | — | ||
| Q4 25 | $99.5M | $2.0M | ||
| Q3 25 | $106.1M | — | ||
| Q2 25 | $100.2M | $455.0M | ||
| Q1 25 | $-217.7M | $11.9M | ||
| Q4 24 | $60.8M | — | ||
| Q3 24 | $-6.2M | — | ||
| Q2 24 | $26.3M | $25.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | 37.7% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 48.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 41.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | -13.2% | ||
| Q3 25 | 38.9% | — | ||
| Q2 25 | 41.0% | -1.3% | ||
| Q1 25 | -590.9% | -5.0% | ||
| Q4 24 | 33.3% | — | ||
| Q3 24 | -1.6% | — | ||
| Q2 24 | 24.7% | -9.0% |
| Q1 26 | 22.1% | — | ||
| Q4 25 | 265.6% | 0.7% | ||
| Q3 25 | 44.0% | — | ||
| Q2 25 | 40.9% | 163.8% | ||
| Q1 25 | -699.2% | 3.7% | ||
| Q4 24 | 28.1% | — | ||
| Q3 24 | -3.0% | — | ||
| Q2 24 | 17.1% | 8.4% |
| Q1 26 | $0.29 | — | ||
| Q4 25 | $0.48 | $0.00 | ||
| Q3 25 | $0.53 | — | ||
| Q2 25 | $0.50 | $0.52 | ||
| Q1 25 | $-1.08 | $0.01 | ||
| Q4 24 | $0.29 | — | ||
| Q3 24 | $-0.03 | — | ||
| Q2 24 | $0.16 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $551.7M | $1.4B |
| Total DebtLower is stronger | — | $93.2M |
| Stockholders' EquityBook value | $4.3B | $1.2B |
| Total Assets | $30.6B | $1.8B |
| Debt / EquityLower = less leverage | — | 0.08× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $551.7M | — | ||
| Q4 25 | $507.6M | $1.4B | ||
| Q3 25 | $703.4M | — | ||
| Q2 25 | $948.3M | $1.4B | ||
| Q1 25 | $609.0M | $836.1M | ||
| Q4 24 | $1.9B | — | ||
| Q3 24 | $1.7B | — | ||
| Q2 24 | $1.4B | $802.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $93.2M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $93.4M | ||
| Q1 25 | — | $82.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $82.1M |
| Q1 26 | $4.3B | — | ||
| Q4 25 | $4.3B | $1.2B | ||
| Q3 25 | $3.8B | — | ||
| Q2 25 | $3.7B | $1.2B | ||
| Q1 25 | $3.6B | $759.9M | ||
| Q4 24 | $3.6B | — | ||
| Q3 24 | $3.7B | — | ||
| Q2 24 | $3.0B | $740.1M |
| Q1 26 | $30.6B | — | ||
| Q4 25 | $30.6B | $1.8B | ||
| Q3 25 | $25.5B | — | ||
| Q2 25 | $25.5B | $1.8B | ||
| Q1 25 | $25.0B | $1.3B | ||
| Q4 24 | $25.6B | — | ||
| Q3 24 | $25.5B | — | ||
| Q2 24 | $21.0B | $1.3B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.08× | ||
| Q1 25 | — | 0.11× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.11× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $8.2M |
| Free Cash FlowOCF − Capex | — | $3.4M |
| FCF MarginFCF / Revenue | — | 1.2% |
| Capex IntensityCapex / Revenue | — | 1.8% |
| Cash ConversionOCF / Net Profit | — | 4.21× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-96.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $432.4M | $8.2M | ||
| Q3 25 | $157.1M | — | ||
| Q2 25 | $123.9M | $-72.9M | ||
| Q1 25 | $47.3M | $40.3M | ||
| Q4 24 | $283.8M | — | ||
| Q3 24 | $108.3M | — | ||
| Q2 24 | $54.3M | $-39.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | $3.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-82.2M | ||
| Q1 25 | — | $32.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-49.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.2% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -29.6% | ||
| Q1 25 | — | 10.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -16.3% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.8% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 3.3% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 3.3% |
| Q1 26 | — | — | ||
| Q4 25 | 4.35× | 4.21× | ||
| Q3 25 | 1.48× | — | ||
| Q2 25 | 1.24× | -0.16× | ||
| Q1 25 | — | 3.38× | ||
| Q4 24 | 4.67× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.06× | -1.54× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
